Previous close | 3.0500 |
Open | 3.1160 |
Bid | 3.1120 x 0 |
Ask | 3.2040 x 0 |
Day's range | 3.1160 - 3.1160 |
52-week range | 1.0050 - 6.9950 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Amidst a significant net loss increase, Omeros Corp navigates through promising drug trials and strategic royalty milestones.